gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · SNWVHealthcareSurgical Instruments

SANUWAVE Health, Inc. Common Stock (SNWV)

$5.73−3.37%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$5.93▼ 78.37% in range
Nov 3, 2025Low $4.00 · High $35.34Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

SANUWAVE Health closed at $5.73 on Nov 4, down 3.37%, 83.8% below its 52-week closing high. Volume of 29.6K shares was 0.71× its 20-day average (below normal).

Split-adjusted performance: +10.2% over one month, -64.0% over six months, -79.1% over one year.

In the quarter ended Jun 30, 2026, revenue was $9.74M, down 3.1% from a year earlier, with a net margin of -7.0%.

Short interest was 236.2K shares at the Oct 15 settlement, down 3.8% from the prior report (3.2% of float, 4.7 days to cover).

Market cap$49.3M8.6M shares
Revenue · quarter$9.7M−3.1% YoY
Diluted EPS$-0.08—
P/E · TTM3.4×P/S 1.1×
Net margin-7.0%Gross 76.2%
Dividend yieldNone
52-week range4.00 – 35.34−83.8% from high
Volume29.6K0.71× 20-day avg
Volatility · 60d71.2%Annualised
Short % of float3.2%4.7 days to cover
Net cash-$9.8MCash $9.4M
Next earnings—Not scheduled
Split-adjusted performance
1W +8.7%1M +10.2%3M −4.5%6M −64.0%YTD −80.8%1Y −79.1%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum15
Revenue growth18
Net margin53
Value (low P/E)97
Size32

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short236.2K−3.8% vs prior
Days to cover4.7Settled Oct 15
% of float3.2%
Short vol. 10d49.1%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
SNWVSANUWAVE Health$5.73−3.37%−64.0%−3.1%−7.0%3.4$49.3M
MDAISpectral AI$1.53+2.00%−31.1%−30.4%−118.5%—$49.2MCompare
DXRDaxor$8.91+2.44%−12.1%+2.3%−403.2%—$52.0MCompare
SRTSSensus Healthcare$3.25−1.07%−20.5%−68.7%−382.1%—$53.5MCompare
CVRXCVRx$1.58+14.49%−77.7%+15.6%−89.4%—$42.1MCompare
XTNTXtant Medical Holdings$0.2960+6.47%−48.7%−35.0%−40.9%—$41.5MCompare
TELATELA Bio$0.8378+4.46%−15.4%−4.5%−58.4%—$37.8MCompare
NSPRInspireMD$0.7810+18.71%−32.7%−0.4%−808.8%—$36.6MCompare
NEPHNephros$3.25+0.31%+0.9%+36.2%19.9%20.3$35.3MCompare

News about SANUWAVE Health

All news →
Sanuwave Announces Q2 FY2026 Financial ResultsGlobeNewswire Inc. · Aug 6, 2026▼ NegativeSanuwave Announces Revenues and Financial Results for Q1 FY2026GlobeNewswire Inc. · May 12, 2026NeutralSanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial ResultsGlobeNewswire Inc. · May 6, 2026▲ PositiveSanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-YearGlobeNewswire Inc. · Apr 16, 2026NeutralSanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025GlobeNewswire Inc. · Mar 26, 2026▲ Positive

Quick answers

What does SANUWAVE Health do?
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures.
What is SNWV's market cap?
$49.29M, based on the Nov 4 close of $5.73.
What is SNWV's P/E ratio?
3.4× trailing-twelve-month earnings of $14.31M.
Does SANUWAVE Health pay a dividend?
No regular cash dividend has been paid in the last year.
How much of SNWV is sold short?
236.2K shares, 3.2% of float, as of Oct 15, 2026.
What sector is SNWV in?
Healthcare, in the Surgical Instruments industry.

About SANUWAVE Health

SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.

HQ: Eden Prairie, MN55 employeesListed Oct 8, 2008sanuwave.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology